UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

The New England journal of medicine, 2001-09, Vol.345 (12), p.861-869

2001

Volltextzugriff (PDF)

Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study

Annals of internal medicine, 2003-12, Vol.139 (11), p.901

2003

Volltextzugriff (PDF)

Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2004-07, Vol.292 (1), p.55

2004

Volltextzugriff (PDF)

Hospitalizations for New Heart Failure Among Subjects With Diabetes Mellitus in the RENAAL and LIFE Studies

The American journal of cardiology, 2005-12, Vol.96 (11), p.1530-1536

2005

Volltextzugriff (PDF)

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events

JAMA : the journal of the American Medical Association, 2004-11, Vol.292 (19), p.2343

2004

Volltextzugriff (PDF)

Improving Collection and Analysis of Overall Survival Data

Clinical cancer research, 2024-09, Vol.30 (18), p.3974-3982

2024

Volltextzugriff (PDF)

Patient-Identified Most Bothersome Symptom in Patients with Chronic Migraine: An Analysis of PROMISE-2 (541)

Neurology, 2020-04, Vol.94 (15_supplement)

2020

Volltextzugriff (PDF)

Daprodustat and On-Treatment Cardiovascular Events in Chronic Kidney Disease. Reply

The New England journal of medicine, 2022-12, Vol.387 (26), p.2482

2022

Volltextzugriff (PDF)

Daprodustat and On-Treatment Cardiovascular Events in Chronic Kidney Disease

The New England journal of medicine, 2022-12, Vol.387 (26), p.2481-2485

2022

Volltextzugriff (PDF)

Tirofiban therapy for patients with acute coronary syndromes and prior coronary artery bypass grafting in the PRISM-PLUS trial

The American journal of cardiology, 2004-04, Vol.93 (7), p.843-847

2004

Volltextzugriff (PDF)

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

The Lancet (British edition), 2002-03, Vol.359 (9311), p.1004-1010

2002

Volltextzugriff (PDF)

Remaining Challenges in Assessing Non-Inferiority

Therapeutic innovation & regulatory science, 2014-01, Vol.48 (1), p.62-67

2014

Volltextzugriff (PDF)

Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy

JAMA : the journal of the American Medical Association, 2002-09, Vol.288 (12), p.1491

2002

Volltextzugriff (PDF)

Incorporation of Clinical Meaningfulness Into the Analysis of a Continuous Variable: A More Powerful Alternative to the Responder Analysis

Statistics in biopharmaceutical research, 2014-10, Vol.6 (4), p.349-355

2014

Volltextzugriff (PDF)

Statistical Considerations on the Evaluation of Imbalances of Adverse Events in Randomized Clinical Trials

Therapeutic innovation & regulatory science, 2015-11, Vol.49 (6), p.957-965

2015

Volltextzugriff (PDF)

Choosing Appropriate Metrics to Evaluate Adverse Events in Safety Evaluation

Therapeutic innovation & regulatory science, 2015-05, Vol.49 (3), p.398-404

2015

Volltextzugriff (PDF)

Effect of combined statin and beta-blocker treatment on one-year morbidity and mortality after acute myocardial infarction associated with heart failure

The American journal of cardiology, 2004-03, Vol.93 (5), p.603-606

2004

Volltextzugriff (PDF)

Interpreting Interaction: The Classical Approach

Drug information journal, 1998, Vol.32 (2), p.433-438

Snapinn, Steven M.

1998

Volltextzugriff (PDF)

Effect of losartan on sudden cardiac death in people with diabetes: data from the LIFE study

The Lancet (British edition), 2003-08, Vol.362 (9384), p.619-620

2003

Volltextzugriff (PDF)

Responsibilities of Data Monitoring Committees: Consensus Recommendations

Therapeutic innovation & regulatory science, 2016-09, Vol.50 (5), p.648-659

2016

Volltextzugriff (PDF)

Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial

Annals of internal medicine, 2003-08, Vol.139 (3), p.169

2003

Volltextzugriff (PDF)

Effect of combined statin and beta-blocker treatment on one-year morbidity and mortality after acute myocordial infarction associated with heart failure

The American journal of cardiology, 2004, Vol.93 (5), p.603-606

2004

Volltextzugriff (PDF)

Evolution of angiographic restenosis rate and late lumen loss after intracoronary beta radiation for in-stent restenotic lesions

The American journal of cardiology, 2004, Vol.93 (7), p.843-847

2004

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Aktive Filter

KollektionPublisher or Other Site

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(21)
Science & Technology
(21)
Humans
(18)
Biological And Medical Sciences
(14)
Medical Sciences
(14)
Male
(13)
Aged
(12)
Female
(12)
Middle Aged
(12)
General & Internal Medicine
(11)
Medicine, General & Internal
(11)
Hypertension - Drug Therapy
(9)
Clinical Trials
(8)
Heart
(8)
Losartan - Therapeutic Use
(8)
Antihypertensive Agents - Therapeutic Use
(7)
Atenolol - Therapeutic Use
(7)
Cardiovascular Disease
(7)
Pharmacology. Drug Treatments
(7)
Cardiology. Vascular System
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study

Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial

Hospitalizations for New Heart Failure Among Subjects With Diabetes Mellitus in the RENAAL and LIFE Studies

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events

Improving Collection and Analysis of Overall Survival Data

Patient-Identified Most Bothersome Symptom in Patients with Chronic Migraine: An Analysis of PROMISE-2 (541)

Daprodustat and On-Treatment Cardiovascular Events in Chronic Kidney Disease. Reply

Daprodustat and On-Treatment Cardiovascular Events in Chronic Kidney Disease

Tirofiban therapy for patients with acute coronary syndromes and prior coronary artery bypass grafting in the PRISM-PLUS trial

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Remaining Challenges in Assessing Non-Inferiority

Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy

Incorporation of Clinical Meaningfulness Into the Analysis of a Continuous Variable: A More Powerful Alternative to the Responder Analysis

Statistical Considerations on the Evaluation of Imbalances of Adverse Events in Randomized Clinical Trials

Choosing Appropriate Metrics to Evaluate Adverse Events in Safety Evaluation

Effect of combined statin and beta-blocker treatment on one-year morbidity and mortality after acute myocardial infarction associated with heart failure

Interpreting Interaction: The Classical Approach

Effect of losartan on sudden cardiac death in people with diabetes: data from the LIFE study

Responsibilities of Data Monitoring Committees: Consensus Recommendations

More on the LIFE study

Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial

Effect of combined statin and beta-blocker treatment on one-year morbidity and mortality after acute myocordial infarction associated with heart failure

More on the LIFE study

Evolution of angiographic restenosis rate and late lumen loss after intracoronary beta radiation for in-stent restenotic lesions

Aktive Filter

Suchergebnisse filtern